alpha-aminopyridine has been researched along with Alloxan Diabetes in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glass, CK; Li, D; Liao, Z; Saltiel, AR; Shen, Z; Sun, X; Witztum, JL; Yu, H; Zhao, P | 1 |
| Aghanoori, MR; Calcutt, NA; Fernyhough, P; Guernsey, L; Han, MM; Johe, K; Jolivalt, CG; Navarro-Diaz, MC; Quach, D; Sanchez, G | 1 |
| Anaya, C; Calcutt, NA; Fernyhough, P; Guernsey, L; Hefferan, M; Johe, K; Jolivalt, CG; Kifle, B; Marquez, A; Muttalib, N; Navarro Diaz, MC; Quach, D; Sanchez, G; Smith, DR | 1 |
| Albuquerque, B; Blatnik, M; Calabrese, MF; Cameron, KO; Cialdea, K; Cokorinos, EC; Cordes, J; Coskran, TM; Delmore, J; Esquejo, RM; Flynn, D; Foretz, M; Jatkar, A; Jørgensen, NO; Kalgutkar, AS; Kindt, E; Kjøbsted, R; Kurumbail, RG; Li, W; Meissen, J; Miller, RA; Moccia, R; Opsahl, AC; Reyes, AR; Salatto, CT; Tess, D; Tran, JL; Viollet, B; Ward, J; Wojtaszewski, JFP | 1 |
| Ding, H; Li, N; Liu, Y; Wang, P; Zhang, P | 1 |
| Alford, T; Anderson, DA; Baer, BR; Bandyopadhyay, G; Chicarelli, MJ; Conn, M; Coward, P; Dewolf, WE; Lagakos, W; Li, P; Lu, M; McVean, M; Véniant, MM; Williams, L | 1 |
| Du, C; Li, Y; Wang, B; Wen, J; Xu, G; Zhang, N; Zhang, Z | 1 |
| Cooke, I; Goodchild, CS; Kolosov, A | 1 |
| Chang, HJ; Cho, JM; Kim, HT; Lee, DY; Lee, SC; Park, CH; Park, S; Ro, S; Suh, YG | 1 |
| Blanchard, SG; Brackeen, MF; Brown, KK; Cobb, JE; Collins, JL; Harrington, WW; Hashim, MA; Henke, BR; Hull-Ryde, EA; Kaldor, I; Kliewer, SA; Lake, DH; Leesnitzer, LM; Lehmann, JM; Lenhard, JM; Miller, JF; Mook, RA; Noble, SA; Oliver, W; Orband-Miller, LA; Parks, DJ; Plunket, KD; Szewczyk, JR; Willson, TM | 1 |
10 other study(ies) available for alpha-aminopyridine and Alloxan Diabetes
| Article | Year |
|---|---|
The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis.
Topics: Aminopyridines; Animals; Atherosclerosis; Bile Acids and Salts; Diabetes Mellitus, Experimental; Humans; Hypercholesterolemia; I-kappa B Kinase; Mice; Protein Serine-Threonine Kinases | 2022 |
Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 Diabetes.
Topics: Aminopyridines; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Mitochondria; Piperazines; Rats; Rats, Zucker | 2022 |
Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189.
Topics: Aminopyridines; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Hippocampus; Male; Mice; Mitochondria; Neurogenesis; Neuronal Outgrowth; Piperazines; Rats; Sensory Receptor Cells; Synapses | 2019 |
Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.
Topics: Aminopyridines; AMP-Activated Protein Kinases; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Enzyme Activation; Enzyme Activators; Female; Glucose; Hypoglycemic Agents; Indoles; Liver; Macaca fascicularis; Male; Mice, Inbred C57BL; Muscle, Skeletal | 2017 |
The phosphodiesterase type 4 inhibitor roflumilast suppresses inflammation to improve diabetic bladder dysfunction rats.
Topics: Aminopyridines; Animals; Benzamides; Cyclopropanes; Cystitis; Diabetes Complications; Diabetes Mellitus, Experimental; Female; Inflammation; Interleukin-1beta; Interleukin-6; NF-kappa B; Phosphodiesterase 4 Inhibitors; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tumor Necrosis Factor-alpha; Urodynamics | 2019 |
Characterization of a novel glucokinase activator in rat and mouse models.
Topics: Aminopyridines; Animals; Area Under Curve; Blood Glucose; Catalysis; Diabetes Mellitus, Experimental; Enzyme Activators; Glucokinase; Glucose; Glucose Tolerance Test; Hepatocytes; Homeostasis; Insulin; Insulin Secretion; Insulin-Secreting Cells; Kinetics; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Phosphorylation; Rats; Rats, Sprague-Dawley; Thiadiazoles | 2014 |
A2B Adenosine Receptor Agonist Improves Erectile Function in Diabetic Rats.
Topics: Adenosine A2 Receptor Agonists; Aminopyridines; Animals; Cyclic AMP; Diabetes Mellitus, Experimental; Electric Stimulation; Erectile Dysfunction; Male; Muscle, Smooth; Neurons; Penile Erection; Penis; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; RNA, Messenger | 2015 |
CNSB004 (Leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic pain.
Topics: Aminopyridines; Analgesics, Non-Narcotic; Animals; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Interactions; Hemodynamics; Hot Temperature; Hyperalgesia; Injections, Intravenous; Male; Motor Activity; omega-Conotoxins; Pain Measurement; Rats; Rats, Wistar | 2010 |
Design, synthesis and biological evaluation of novel imidazopyridines as potential antidiabetic GSK3β inhibitors.
Topics: Administration, Oral; Aminopyridines; Animals; Binding Sites; Blood Glucose; Crystallography, X-Ray; Diabetes Mellitus, Experimental; Drug Design; Glycogen Synthase Kinase 3; Humans; Hypoglycemic Agents; Imidazoles; Male; Mice; Mice, Inbred ICR; Microsomes; Protein Structure, Tertiary; Pyridines; Structure-Activity Relationship | 2012 |
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.
Topics: Administration, Oral; Aminopyridines; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; DNA-Binding Proteins; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Ligands; Lipids; Male; Mice; Oxazoles; Propionates; Radioligand Assay; Rats; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Stereoisomerism; Structure-Activity Relationship; Transcription Factors; Transfection; Tyrosine | 1998 |